Interactive Session - Dilemmas in the Care of Polycystic Ovary Syndrome Patients
Time:1:15 pm - 2:15 pm
Location:HCC301 - Hawaii Convention Center
Kathleen M. Hoeger, M.D., M.P.H. (Chair), University of Rochester Medical Center
Anuja Dokras, M.D., Ph.D., University of Pennsylvania
Helena Teede, M.B.B.S, Ph.D., Monash University
Needs Assessment and Description
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women and impacts 5%-10% of the population. The management of PCOS is often challenging and can vary by presentation and age. This session for clinicians and allied health professionals will provide a discussion of the challenges of diagnosis in various age groups, treatment options in the infertile patient including metformin, and the challenge of obesity in the management of this condition.
At the conclusion of this session, participants should be able to:
- Explain the rationale for the diagnostic criteria in PCOS.
- Discuss the potential complications of obesity in the management of PCOS.
A 25-year-old woman with 35- to 40-day menstrual cycles presents for evaluation. She has been on hormonal contraception since age 17 and stopped recently to attempt conception. She recalls similar menses as an adolescent. She has noted a modest increase in facial hair since stopping the oral contraceptive, and her evaluation thus far indicates no thyroid dysfunction and normal follicle- stimulating hormone (FSH) and prolactin levels. She has a normal physical exam with absence of clitoromegaly or Cushing stigmata, and her total testosterone is 60 ng/ dL (upper limits of normal for the lab = 50 ng/dL). Her body mass index is 25 kg/m2. After participating in this session, in my practice the next step in the diagnosis of her menstrual dysfunction would be:
a. Dehydroepiandrosterone sulfate (DHEAS) level
b. Luteinizing hormone (LH) testing
c. Ovarian ultrasound
d. Free testosterone level
e. Not applicable to my area of practice